Research Article

The Ratio of CD226 and TIGIT Expression in Tfh and PD-1+ICOS+Tfh Cells Are Potential Biomarkers for Chronic Antibody-Mediated Rejection in Kidney Transplantation

Figure 1

Gating strategy for analysis using logic gates. Measurements were performed with fresh blood samples. (a) Tfh cells were defined as CD4+CXCR5+ T cells in the lymphocyte population. The Tfh cell phenotypes were PD-1+ICOS+CD4+CXCR5+ T cell (PD-1+ICOS+Tfh cells), CD226+CD4+CXCR5+ T cell (CD226+Tfh cells), and TIGIT+CD4+CXCR5+ T cell (TIGIT+Tfh cells). (b) B cells were further defined as CD19-expressing cells in the lymphocyte population. CD19+ B cells were analyzed for the expressions of IgD and CD27, CD24, and CD38. The B cell populations included CD27-IgD+ (naïve B cells), CD27+IgD+ (unswitched memory B cells), CD27+IgD- (switched memory B cells), CD24++CD38++ (transitional B cells), CD27+CD38+ (plasmablasts), and CD38+ B cells (plasma cells).
(a)
(b)